ICAD INC. - COMMON STO

iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists

19 مارس 2024 09:00:00 بحسب Nasdaq GlobeNewswire

iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results

12 مارس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

28 فبراير 2024 08:05:00 بحسب Nasdaq GlobeNewswire

iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)

27 فبراير 2024 09:05:00 بحسب Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

27 فبراير 2024 08:05:00 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

06 فبراير 2024 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member

30 يناير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD Expands Executive Sales Leadership Team as Business Grows

18 ديسمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

27 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution  

20 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference

14 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for Third Quarter Ended September 30, 2023

13 نوفمبر 2023 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023

30 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

23 أكتوبر 2023 08:01:00 بحسب Nasdaq GlobeNewswire

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

16 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 

14 أغسطس 2023 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

14 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023

31 يوليو 2023 08:00:00 بحسب Nasdaq GlobeNewswire

iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice

18 يوليو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic

12 يوليو 2023 08:00:00 بحسب Nasdaq GlobeNewswire